BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 30913473)

  • 1. Genie in a bottle: controlled release helps tame natural polypharmacology?
    Long MJ; Liu X; Aye Y
    Curr Opin Chem Biol; 2019 Aug; 51():48-56. PubMed ID: 30913473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An Oculus to Profile and Probe Target Engagement In Vivo: How T-REX Was Born and Its Evolution into G-REX.
    Long MJC; Rogg C; Aye Y
    Acc Chem Res; 2021 Feb; 54(3):618-631. PubMed ID: 33228351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The polypharmacology of natural products.
    Ho TT; Tran QT; Chai CL
    Future Med Chem; 2018 Jun; 10(11):1361-1368. PubMed ID: 29673257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MTLD, a Database of Multiple Target Ligands, the Updated Version.
    Chen C; Wu M; Cen S; Wu J; Zhou J
    Molecules; 2017 Sep; 22(9):. PubMed ID: 28878188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High Impact: The Role of Promiscuous Binding Sites in Polypharmacology.
    Cerisier N; Petitjean M; Regad L; Bayard Q; Réau M; Badel A; Camproux AC
    Molecules; 2019 Jul; 24(14):. PubMed ID: 31295958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polypharmacology rescored: protein-ligand interaction profiles for remote binding site similarity assessment.
    Salentin S; Haupt VJ; Daminelli S; Schroeder M
    Prog Biophys Mol Biol; 2014; 116(2-3):174-86. PubMed ID: 24923864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In silico polypharmacology of natural products.
    Fang J; Liu C; Wang Q; Lin P; Cheng F
    Brief Bioinform; 2018 Nov; 19(6):1153-1171. PubMed ID: 28460068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polypharmacology in the Treatment of Chagas Disease.
    Aguilera E; Alvarez G; Cerecetto H; González M
    Curr Med Chem; 2019; 26(23):4476-4489. PubMed ID: 29637852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progress in the Rational Design for Polypharmacology Drug.
    Zhou J; Li Q; Wu M; Chen C; Cen S
    Curr Pharm Des; 2016; 22(21):3182-9. PubMed ID: 26907948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic Potential of Natural Psychoactive Drugs for Central Nervous System Disorders: A Perspective from Polypharmacology.
    Oña G; Bouso JC
    Curr Med Chem; 2021; 28(1):53-68. PubMed ID: 31830883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Covalent inhibitors: an opportunity for rational target selectivity.
    Lagoutte R; Patouret R; Winssinger N
    Curr Opin Chem Biol; 2017 Aug; 39():54-63. PubMed ID: 28609675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polypharmacology in Drug Development: A Minireview of Current Technologies.
    Tan Z; Chaudhai R; Zhang S
    ChemMedChem; 2016 Jun; 11(12):1211-8. PubMed ID: 27154144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identifying Promiscuous Compounds with Activity against Different Target Classes.
    Feldmann C; Miljković F; Yonchev D; Bajorath J
    Molecules; 2019 Nov; 24(22):. PubMed ID: 31752252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantifying the tendency of therapeutic target proteins to bind promiscuous or selective compounds.
    Hu Y; Bajorath J
    PLoS One; 2015; 10(5):e0126838. PubMed ID: 26000736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. From biased signalling to polypharmacology: unlocking unique intracellular signalling using pepducins.
    Carr R; Benovic JL
    Biochem Soc Trans; 2016 Apr; 44(2):555-61. PubMed ID: 27068969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phytomedicine polypharmacology: Cancer therapy through modulating the tumor microenvironment and oxylipin dynamics.
    Apaya MK; Chang MT; Shyur LF
    Pharmacol Ther; 2016 Jun; 162():58-68. PubMed ID: 26969215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Web-Based Tools for Polypharmacology Prediction.
    Awale M; Reymond JL
    Methods Mol Biol; 2019; 1888():255-272. PubMed ID: 30519952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Binding site comparisons for target-centered drug discovery.
    Konc J
    Expert Opin Drug Discov; 2019 May; 14(5):445-454. PubMed ID: 30856011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polypharmacology: in silico methods of ligand design and development.
    McKie SA
    Future Med Chem; 2016 Apr; 8(5):579-602. PubMed ID: 27105127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteomics and Beyond: Cell Decision-Making Shaped by Reactive Electrophiles.
    Liu X; Long MJC; Aye Y
    Trends Biochem Sci; 2019 Jan; 44(1):75-89. PubMed ID: 30327250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.